These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15883102)

  • 21. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal hormone therapy and breast cancer: what is the problem?
    Kenemans P
    Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy.
    Milewicz A; Szymański W; Ruzyłło W; Zgliczyński S; Reinfus M; Zieliński J; Debski R; Demissie M; Tworowska U
    Gynecol Endocrinol; 2002 Oct; 16(5):385-9. PubMed ID: 12587533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
    Genazzani AR; Schneider HP; Panay N; Nijland EA
    Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

  • 31. [The Danish Nurse Cohort Study 1993-2003].
    Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
    Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
    [No Abstract]   [Full Text] [Related]  

  • 32. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].
    Zhang YW
    Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037
    [No Abstract]   [Full Text] [Related]  

  • 34. Decision factors influencing hormone replacement therapy.
    Rozenberg S; Kroll M; Vandromme J
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():92-7; discussion 97-8. PubMed ID: 8624351
    [No Abstract]   [Full Text] [Related]  

  • 35. Rethinking postmenopausal hormone therapy.
    Solomon CG; Dluhy RG
    N Engl J Med; 2003 Feb; 348(7):579-80. PubMed ID: 12584364
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy.
    Reid IR
    N Z Med J; 1994 Apr; 107(975):138. PubMed ID: 8145969
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 39. Postmenopausal estrogen therapy and cardiovascular disease.
    Fleming BJ
    N Engl J Med; 1992 Mar; 326(10):705; author reply 707. PubMed ID: 1736111
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone replacement therapy: benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer.
    Bluming AZ
    Semin Oncol; 1993 Dec; 20(6):662-74. PubMed ID: 8296203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.